Ginkgo Bioworks Holdings (DNA) Ownership - Who Owns Ginkgo Bioworks Holdings?
Ginkgo Bioworks Holdings (DNA) Ownership Overview
- 3.85% Insiders
- 16.71% Mutual Funds
- 2.58% Other Institutional Investors
- 15.78% ETFs
- 61.09% Public Companies and Individual Investors
The ownership structure of Ginkgo Bioworks Holdings (MX:DNA) stock is a mix of institutional, retail, and individual investors. Approximately 35.07% of the company’s stock is owned by Institutional Investors, 3.85% is owned by Insiders, and 61.09% is owned by Public Companies and Individual Investors.
The ownership structure of Ginkgo Bioworks Holdings (MX:DNA) stock is a mix of institutional, retail, and individual investors. Approximately 35.07% of the company’s stock is owned by Institutional Investors, 3.85% is owned by Insiders, and 61.09% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
| Date | Name | Activity | Value |
|---|
Recent Hedge Fund Trading Activity
| Date | Firm | Activity | Value |
|---|
Top Shareholders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| BlackRock, Inc. | 4,282,903 | Institution | 7.73% | 26,665,354 |
| Andreas Halvorsen | 3,577,128 | Institution | 6.46% | 22,271,199 |
| Vanguard | 2,511,144 | Institution | 4.53% | 15,634,383 |
| Ishares | 2,467,664 | Institution | 4.46% | 15,363,676 |
| Tiaa-cref Funds | 2,117,620 | Institution | 3.82% | 13,184,302 |
| Vanguard Index Funds | 2,039,922 | Institution | 3.68% | 12,700,554 |
| Fidelity Commonwealth Trust Ii | 1,904,642 | Institution | 3.44% | 11,858,301 |
| L&g | 1,812,956 | Institution | 3.27% | 11,287,464 |
| Kevin Ulrich | 1,746,363 | Institution | 3.15% | 10,872,856 |
| Reshma P. Shetty | 810,280 | Insider | 1.46% | 5,044,803 |
Top Mutual Fund Holders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Tiaa-cref Funds | 2,117,620 | Institution | 3.82% | 13,184,302 |
| Vanguard Index Funds | 2,039,922 | Institution | 3.68% | 12,700,554 |
| Fidelity Commonwealth Trust Ii | 1,904,642 | Institution | 3.44% | 11,858,301 |
| Fidelity Salem Street Trust | 597,429 | Institution | 1.08% | 3,719,593 |
| Pimco Equity Series | 506,312 | Institution | 0.91% | 3,152,299 |
| Fidelity Concord Street Trust | 460,979 | Institution | 0.83% | 2,870,055 |
| Vanguard Scottsdale Funds | 319,878 | Institution | 0.58% | 1,991,560 |
| Vanguard Explorer Fund | 251,437 | Institution | 0.45% | 1,565,447 |
| Vanguard Horizon Funds | 234,539 | Institution | 0.42% | 1,460,240 |
| Dfa Investment Dimensions Group Inc | 185,852 | Institution | 0.34% | 1,157,115 |
FAQ
Who Owns Ginkgo Bioworks Holdings (MX:DNA)?
According to the latest TipRanks data, approximately 35.07% of the company's stock is held by institutional investors, 3.85% is held by insiders, and 61.09% is held by public companies and individual investors.
What percentage of Ginkgo Bioworks Holdings (MX:DNA) stock is held by institutional investors?
According to the latest TipRanks data, approximately 35.07% of Ginkgo Bioworks Holdings (MX:DNA) stock is held by institutional investors: 16.71% by mutual funds, 15.78% by ETFs and 2.58% by other institutional investors.
What percentage of Ginkgo Bioworks Holdings (MX:DNA) stock is held by retail investors?
According to the latest TipRanks data, approximately 61.09% of Ginkgo Bioworks Holdings (MX:DNA) stock is held by public companies and individual investors.
Who owns the most shares of Ginkgo Bioworks Holdings (MX:DNA)?
BlackRock, Inc. owns the most shares of Ginkgo Bioworks Holdings (MX:DNA).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
